secwatch.observer — SEC 8-K summary
======================================

Issuer:     DiaMedica Therapeutics Inc. (DMAC)
CIK:        0001401040
Form:       8-K
Filed at:   2022-06-29T23:59:59+00:00
Accession:  0001437749-22-016176
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DiaMedica Therapeutics subsidiary enters office lease for new headquarters in Minnetonka, MN
--------------------------------------------------------------------------------

- Lease for approx 6,175 sq ft at 301 Carlson Parkway, Suite 210, Minnetonka, MN.
- Initial term 5 years 5 months starting Sept 1, 2022, with option to extend 5 years.
- Rent approx $9,000/month after 5-month abatement, plus share of operating expenses and taxes.
- Company to relocate principal executive offices and R&D operations from current Plymouth location.
- Parent company DiaMedica Therapeutics provides lease guaranty; security deposit $8,750.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401040/000143774922016176/0001437749-22-016176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401040/000143774922016176/dmtp20220623_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-016176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer